LLYEli LillyNeutralEli LillyABVXAbivaxBearishAbivax
2w ago on
China's coming for $ABVX!!! $lly would rather do a $1B deal with Hengrui than pay $15B for $ABVX. We need to be real, numbers dont lie. https://t.co/7ySzFjifS3
View original →
Opportunistic biotech trading bitch with a focus on nucleic acid-based and -targeted biotech. Fiercely independent. https://t.co/dfLqOuH7Uh
Cite asCryptoQuant has tracked the directional calls on LLY by @RNAiAnalyst on X since Aug 2025: not yet scored on LLY (as of Nov 11, 2026).
Other assets covered (14)
3 LLY calls on record, a thin history.
Relative view by default: fewer than 30 LLY calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @RNAiAnalyst to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
China's coming for $ABVX!!! $lly would rather do a $1B deal with Hengrui than pay $15B for $ABVX. We need to be real, numbers dont lie. https://t.co/7ySzFjifS3
View original →The China deals are picking up pace (Roche, Lilly today) by the day while Western M&A and deal activity has ground to a halt. Is Big Pharma prioritizing China deals now before politicians clamp down? https://t.co/RpkD9IVHqt
View original →
